Ius Fabio, Koigeldiyev Nurbol, Roumieh Mazen, Ismail Issam, Tudorache Igor, Shrestha Malakh, Fleissner Felix, Haverich Axel, Cebotari Serghei
Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany
Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Eur J Cardiothorac Surg. 2016 Jun;49(6):1676-84. doi: 10.1093/ejcts/ezv425. Epub 2015 Dec 12.
The effect of sinuses of Valsalva on aortic bioprosthesis durability has not been investigated so far. The aim of this study was to compare durability of the Carpentier-Edwards aortic bioprosthesis in patients undergoing aortic valve and ascending aorta replacement as a composite bioconduit (Group A, case group) versus patients undergoing separate replacement of the aortic valve and ascending aorta, with preservation of the aortic root (Group B, control group), between January 2000 and January 2014.
Records of Group A (n = 133) and Group B (n = 162) patients were retrospectively reviewed. End-points were evaluated among groups in three ways: before and after propensity score 1:1 matching (Group A, n = 94; Group B, n = 94 patients) and after patient stratification through quintiles of propensity scores.
There was no difference among groups regarding mean and maximal trans-prosthetic pressure gradients at discharge (P = 0.07 and 0.45, respectively). Maximal trans-prosthetic gradients were lower in Group A patients at last control (P = 0.03). Structural valve deterioration (SVD) was due to prosthesis regurgitation (Group A, n = 5; Group B, n = 1), stenosis (Group A, n = 2; Group B, n = 5) or combined (Group A, n = 4; Group B, n = 2). After a mean follow-up of 68 ± 42 months, there was no difference among groups, at 5 and 12 years, regarding mortality, freedom from SVD, from redo aortic valve replacement for SVD and cardiac redo of any type, before and after matching and after stratification according to quintiles of propensity scores.
Within the 12-year follow-up, the absence of the sinuses of Valsalva seems to have no influence on durability of Carpentier Edwards aortic bioprosthesis. Longer follow-up may be warranted.
目前尚未研究主动脉瓣窦对主动脉生物瓣耐久性的影响。本研究旨在比较2000年1月至2014年1月期间,接受主动脉瓣和升主动脉置换作为复合生物管道的患者(A组,病例组)与接受主动脉瓣和升主动脉分别置换且保留主动脉根部的患者(B组,对照组)中,Carpentier-Edwards主动脉生物瓣的耐久性。
回顾性分析A组(n = 133)和B组(n = 162)患者的记录。通过三种方式对组间终点进行评估:倾向得分1:1匹配前后(A组,n = 94;B组,n = 94例患者)以及通过倾向得分五分位数对患者进行分层后。
出院时,各组间平均和最大跨瓣压力梯度无差异(分别为P = 0.07和0.45)。最后一次随访时,A组患者的最大跨瓣梯度较低(P = 0.03)。结构性瓣膜退变(SVD)是由人工瓣膜反流(A组,n = 5;B组,n = 1)、狭窄(A组,n = 2;B组,n = 5)或两者兼有(A组,n = 4;B组,n = 2)引起。平均随访68±42个月后,在匹配前后以及根据倾向得分五分位数分层后,各组在5年和12年时的死亡率、无SVD、因SVD再次行主动脉瓣置换以及任何类型的心脏再次手术方面无差异。
在12年的随访期内,无主动脉瓣窦似乎对Carpentier Edwards主动脉生物瓣的耐久性没有影响。可能需要更长时间的随访。